Actively Recruiting
Pilot Study Evaluating AI-Based Cardiac Disease Analysis Using 12-Lead and Single-Lead ECG at Inha University Hospital
Led by Inha University Hospital · Updated on 2026-10-30
300
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical performance and usefulness of the SmartECG-EF software in patients who undergo cardiac evaluations at Inha University Hospital. The study focuses on how well this device supports clinicians in assessing heart function and related clinical factors. This prospective pilot study aims to gather real-world data to improve diagnostic accuracy and patient care. Participants will receive standard clinical evaluations along with assessments using the SmartECG-EF software, which analyzes 12-lead and 1-lead electrocardiogram ECG data to evaluate heart function, including left ventricular systolic dysfunction, heart failure signs, and arrhythmia-related parameters. This single-center study integrates the software into routine practice to test its diagnostic usefulness and operational workflow. During the study, participants will undergo standard 12-lead ECG and additional 1-lead ECG measurements during the same visit. Researchers will collect and analyze data on clinical parameters, primary outcomes like the correlation between AI scores from 12-lead and 1-lead ECGs, and secondary outcomes such as sensitivity, specificity, and area under the curve of AI scores. Safety monitoring includes recording any device-related adverse events. The study runs from November 2026 to March 2028.
CONDITIONS
Brief Title
AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG
Research Team
Y
Yongsoo Baek, M.D., Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here